Evaluating Back-to-Back and Day-to-Day Reproducibility of Cortical GABA+ Measurements Using Proton Magnetic Resonance Spectroscopy (1H MRS)
Open Access
- 23 April 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (9) , 7713
Abstract
γ-aminobutyric acid (GABA) is a major inhibitory neurotransmitter implicated in neuropsychiatric disorders. The best method for quantifying GABA is proton magnetic resonance spectroscopy (1H MRS). Considering that accurate measurements of GABA are affected by slight methodological alterations, demonstrating GABA reproducibility in healthy volunteers is essential before implementing the changes in vivo. Thus, our study aimed to evaluate the back-to-back (B2B) and day-to-day (D2D) reproducibility of GABA+ macromolecules (GABA+) using a 3 Tesla MRI scanner, the new 32-channel head coil (CHC), and Mescher–Garwood Point Resolved Spectroscopy (MEGA-PRESS) technique with the scan time (approximately 10 min), adequate for psychiatric patients. The dorsomedial pre-frontal cortex/anterior cingulate cortex (dmPFC/ACC) was scanned in 29 and the dorsolateral pre-frontal cortex (dlPFC) in 28 healthy volunteers on two separate days. Gannet 3.1 was used to quantify GABA+. The reproducibility was evaluated by Pearson’s r correlation, the interclass-correlation coefficient (ICC), and the coefficient of variation (CV%) (r/ICC/CV%). For Day 1, B2B reproducibility was 0.59/0.60/5.02% in the dmPFC/ACC and 0.74/0.73/5.15% for dlPFC. For Day 2, it was 0.60/0.59/6.26% for the dmPFC/ACC and 0.54/0.54/6.89 for dlPFC. D2D reproducibility of averaged GABA+ was 0.62/0.61/4.95% for the dmPFC/ACC and 0.58/0.58/5.85% for dlPFC. Our study found excellent GABA+ repeatability and reliability in the dmPFC/ACC and dlPFC.Keywords
Funding Information
- Canopy Mitacs Grant (IT12914)
- Pfizer Inc. (IT12914)
- Indivior (IT12914)
- Aurora Cannabis Enterprises Inc. (IT12914)
- Bioprojet Pharma (IT12914)
- BrainsWay (IT12914)
- Canopy Growth Corporation (IT12914)
- Alcohol Countermeasure Systems (ACS) (IT12914)
- Alkermes (IT12914)
- Universal Ibogaine (IT12914)
- Indivior Canada National Advisory Board (IT12914)
- CAMH and Waypoint Centre for Mental Health Care (IT12914)
- University of Toronto (IT12914)
This publication has 52 references indexed in Scilit:
- The "Stop" and "Go" of Nicotine Dependence: Role of GABA and GlutamateCold Spring Harbor Perspectives in Medicine, 2013
- Regional difference in GABA levels between medial prefrontal and occipital corticesJournal of Magnetic Resonance Imaging, 2013
- Absence of changes in GABA concentrations with age and gender in the human anterior cingulate cortex: A MEGA‐PRESS study with symmetric editing pulse frequencies for macromolecule suppressionMagnetic Resonance in Medicine, 2012
- In vivo magnetic resonance spectroscopy of GABA: A methodological reviewProgress in Nuclear Magnetic Resonance Spectroscopy, 2012
- In vivo detection of GABA and glutamate with MEGA‐PRESS: Reproducibility and gender effectsJournal of Magnetic Resonance Imaging, 2011
- Effect of Acute Psychological Stress on Prefrontal GABA Concentration Determined by Proton Magnetic Resonance SpectroscopyAmerican Journal of Psychiatry, 2010
- Quantitative Proton Magnetic Resonance Spectroscopy and Spectroscopic Imaging of the BrainTopics in Magnetic Resonance Imaging, 2010
- Prefrontal Cortical Gamma-Aminobutyric Acid Levels in Panic Disorder Determined by Proton Magnetic Resonance SpectroscopyBiological Psychiatry, 2009
- Grey and white matter GABA level differences in the human brain using two‐dimensional, J‐resolved spectroscopic imagingNMR in Biomedicine, 2005
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986